Mycrodose Therapeutics to Discuss Advanced Drug Delivery Devices at Psychedelic Medicine Event
San Diego, California--(Newsfile Corp. - July 27, 2021) - Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021.
- San Diego, California--(Newsfile Corp. - July 27, 2021) - Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021.
- The virtual conference hosted by Microdose Psychedelic Insights will enable Mycrodose Therapeutics the opportunity to present as a panel on the companys core drug delivery systems, their major milestones & accomplishments, and the companys outlook on the expanding psychedelic pharmaceutical sector.
- Mycrodose Therapeutics started from a deep personal need to find better solutions for treating mental health.
- Tickets: FREE Only Through This Link: https://microdose.buzz/discount/psycap/
Mycrodose Therapeutics is a US-Based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases.